Briefing
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
In the BioRAIDs cervical-cancer cohort, HPV E7 ctDNA was the most sensitive serum marker; complete clearance by the end of treatment was associated with longer PFS, and patients with persistent HPV ctDNA relapsed at a median of 10 months from first detection.
- Design: Evidence level 3
- Assay: Not named in the abstract
Clin Cancer ResPubMed 34210686DOI 10.1158/1078-0432.CCR-21-0625